Please login to the form below
Evotec CEO Werner Lanthaler temporarily stands down
Cites health reasons
Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.
Dr Lanthaler informed the supervisory board of his situation, and the board approved approved his leave of absence. It also wished Dr Lanthaler an early recovery.
The management board of Dr Cord Dohrmann and Colin Bond, under the direction of Dr Mario Polywka, the chief operating officer, will lead the company in the absence of Dr Lanthaler.
He will reassume the role of CEO as soon as he has recovered.
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Boehringer Ingelheim and Lilly launch diabetes education campaign
- GSK to set up online system for trial data requests
- Former Google chief launches online cancer forum
- Global biosimilars market to reach $2.45bn in 2013
- Value-based pricing "not in patient interest"
PMHub
Add my companyinVentiv Health Communications Europe
Wherever you are, turn to Junction 11 Whatever the communication vehicle and whether your brand is at the beginning of its ...
Latest intelligence
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
- A guide to developing customer-centred, multichannel marketing
- Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in ...
Quick links
